YONG TAI BERHAD - ICPS 2016/2026
KLSE (MYR): YONGTAI-PA (7066PA)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.035
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Discussions
1 person likes this. Showing 39 of 39 comments
what is the interest coupon for this PA? I went to Bursa website and could not find anything. it mention :
"The Company have the sole discretion to decide whether to declare any non-cumulative dividend to the holders of ICPS. They do not have the right to participate in any additional distributions declared for ordinary shareholders"
Does this means this is not usual type of PA where no interests coupon will be paid? and they only declare dividend and this is at the discretion of the company? which also mean unlikely to receive any dividend too?
2018-02-19 12:24
can anyone enlighten me as to the conversion price of RM0.80 sen.
1. Does that means we need to pay additional to convert?
2. Assuming that the shareholders converts, what is the dilution effects on the mother shares?
Thank you
2018-04-02 16:00
Wow..price below mother share, it's time to accumulate like a fixed deposit due on Nov 2019
2018-08-30 08:20
PA almost at all time low now 0.20 compared with all time low share price 0.30, share price now 0.36, buy more PA @0.20 targetted for conversion to share commencing in November 2019, 1 to 1 basis, no need to pay a single sen extra for conversion !!! Conversion discount now very attractive at 45% !!!
2019-03-07 15:54
where can we check that the conversion is 1 to 1 basis without any fee?
2019-04-19 08:18
Please call the Share Registrar or better still the Company Secretary to confirm conversion is 1 to 1 without any further payment except for normal conversion fee of RM20 per conversion with conversion period commencing from November 2019 onwards !!!
2019-04-19 09:53
Yes its true. Conversion discount is now still very attractive at 34%, too big to ignore !!!
2019-04-19 17:06
With the further special share issue of 400M@36 sen by second half 2019, it will even be more interesting for PA now at 25 sen from now to conversion period starting from 28 November this year !!! Conversion discount now still significant n attractive at around 30% !!!
2019-05-18 20:25
Kris, besides calling the company secretary, is there any document posted for investor's knowledge with regard to the conversion 1 to 1 without any further payment....
2019-06-28 14:58
Can also call the Share Registrar to confirm. If can, also get them to email u the CONVERSION FORM provided they already drafted it out as the conversion on a 1 to 1 basis without any further payment can only be done from 28 November this year !!! ( note : no further payment is needed as this PA (convertible preference share) is already fully paid and issued at 80 sen and the conversion price is also 80 sen to convert to ordinary share, therefore no need further payment for conversion)
2019-06-30 00:19
YONTAI shows a signs of a promising Rally
Buy AT 0.300
For SL and Target contact me at Telegram - @KLSEstock
2021-01-11 10:45
--Private vaccine sales start in Aug--
PUTRAJAYA: Pharmaceutical companies will be allowed to sell vaccines on the private market starting in August, says National Covid-19 Immunisation Programme coordinating minister Khairy Jamaluddin.
“The Special Committee on Ensuring Access to Covid-19 Vaccine Supply (JKJAV) will meet next week to decide on the guidelines for the private sale of vaccines, including the ceiling price,” he said at his weekly joint media briefing with Health Minister Datuk Seri Dr Adham Baba yesterday.
Khairy added that the cap on prices is to ensure that the vaccines would not be sold at too high a price.
“A lot of people have been asking why we don’t open up the private market for people who are willing to pay.
https://www.facebook.com/malaysianewslab/photos/a.256073469518672/496335928825757
2021-07-24 19:34
康泰生物：成功分离德尔塔变异株，为生产灭活新冠疫苗做准备
新冠病毒德尔塔变异毒株引发的本土疫情还在蔓延，中国新冠灭活疫苗能否应对德尔塔变异毒株？又一家新冠疫苗生产企业作出回应。8月4日下午，澎湃新闻从深圳康泰生物制品股份有限公司获悉，该公司针对新冠病毒变异株的研发项目取得重要进展，已经成功分离出多株新冠病毒德尔塔变异株单克隆毒种，后续将严格按照人用疫苗质量要求进行毒株评价，筛选疫苗用毒种，为生产针对德尔塔变异株的新冠灭活疫苗做好准备。
康泰生物有关负责人表示，公司内部进行的交叉中和实验结果显示，截至目前，已获批紧急使用的康泰生物新冠灭活疫苗对多种新冠变异株也能够产生良好的中和反应，仍具有保护性。
https://mbd.baidu.com/newspage/data/landingsuper?context=%7B%22nid%22%3A%22news_9575015010923836348%22%7D&n_type=-1&p_from=-1
2021-08-05 10:50
是真的消息哦！
8月4日，记者从位于光明区的深圳康泰生物制品股份有限公司生产基地了解到，该公司针对新冠病毒变异株的疫苗研发项目取得重要进展，已经成功分离出多株德尔塔变异株单克隆毒种，后续将严格按照人用疫苗质量要求进行毒株评价，筛选疫苗用毒种，为生产针对德尔塔变异株的新冠灭活疫苗做好准备。
此外，公司内部进行的交叉中和实验结果显示：截至目前，已获批紧急使用的“可维克”新冠灭活疫苗对多种新冠变异株也能够产生良好的中和反应，仍具有保护性。
https://mil.news.sina.com.cn/2021-08-05/doc-ikqcfncc1025059.shtml
2021-08-05 10:54
The COVID-19 vaccine produced by Shenzhen Kangtai Biological Products can protect against various mutations of the novel coronavirus, including the increasingly dominant Delta variant, the company told the Global Times on Wednesday.
The company said it had recently succeeded in isolating the Delta strain and would continue to evaluate it for further vaccine development.
Kangtai's COVID-19 vaccine was approved in China for emergency use in May. The company previously announced that data collected during the Phase I and II clinical trials showed a strong antibody response.
https://www.globaltimes.cn/page/202108/1230594.shtml
2021-08-05 11:08
由于国内政局动荡、疫情又陰影不散，我国股市已经跌破1500点心理水平，不但外资在7月净卖57亿本地股票、马币更眨值至一美元兑换4.24令吉关口。大马股市今年来下滑高达8.53%, 是整个亚太区表现最差劲的股市。
很多投機者，賭博心態，輸了就來怪天賴地。
好笑。
2021-08-05 12:58
so many cases that people who vaccinated 1 or 2 dose also infected, we need more effective vaccine to save lifes.
2021-08-10 13:33
今年的50大富豪榜有三名新面孔，分别是2019年起在新加坡定居的加密货币交易平台币安（Binance）创办人赵长鹏（19亿美元、排名第22）、纳峰科技（Nanofilm Technologies）集团执行主席史旭博士（18亿美元，排名第34）和私召车平台Grab联合创办人陈炳耀（7.9亿元，排名第47）。
加密货币前途無量！！！
https://www.klsescreener.com/v2/news/view/866509/%E6%8C%A4%E4%B8%8B%E5%BC%A0%E5%8B%87-%E6%9D%8E%E8%A5%BF%E5%BB%B7%E6%88%90%E6%96%B0%E5%8A%A0%E5%9D%A1%E9%A6%96%E5%AF%8C
2021-08-12 16:47
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lai81533
Cheap and good
2017-04-08 01:48